U.S. steps up efforts to develop blood-related therapies for COVID-19

The U.S. FDA is taking the lead on national efforts to facilitate the development of, and access to, two investigational therapies for COVID-19 derived from human blood, according to a release of the agency on April 3.

Leave a Comment